Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- 69542
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Swissmedic Registration
69542
Date of registration
26.10.2023
Company name
Novartis Pharma Schweiz AG
Revision date
Valid until
25.10.2028
Indication
Date of market entry
Index Therapeuticus (BSV)
Revocation Date
Index Therapeuticus (Swissmedic)
07.15.
Information for professionals
IP
Seq.-No.
Product
Description
Galenic form
ATC-classification
01
Simulect 20 mg
Pulver zur Herstellung einer Injektions-/Infusionslösung
Dry substance (Basiliximab 20 mg)
L04AC02
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
